Glucagon actions on the kidney revisited: possible role in potassium homeostasis
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
It is now recognized that the metabolic disorders observed in diabetes are not, or not only due to the lack of insulin or insulin resistance, but also to elevated glucagon secretion. Accordingly, selective glucagon receptor antagonists are now proposed as a novel strategy for the treatment of diabetes. However, besides its metabolic actions, glucagon also influences kidney function. The glucagon receptor is expressed in the thick ascending limb, distal tubule, and collecting duct, and glucagon regulates the transepithelial transport of several solutes in these nephron segments. Moreover, it also influences solute transport in the proximal tubule, possibly by an indirect mechanism. This review summarizes the knowledge accumulated over the last 30 years about the influence of glucagon on the renal handling of electrolytes and urea. It also describes a possible novel role of glucagon in the short-term regulation of potassium homeostasis. Several original findings suggest that pancreatic α-cells may express a “potassium sensor” sensitive to changes in plasma K concentration and could respond by adapting glucagon secretion that, in turn, would regulate urinary K excretion. By their combined actions, glucagon and insulin, working in a combinatory mode, could ensure an independent regulation of both plasma glucose and plasma K concentrations. The results and hypotheses reviewed here suggest that the use of glucagon receptor antagonists for the treatment of diabetes should take into account their potential consequences on electrolyte handling by the kidney.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Glucagonocentric restructuring of diabetes: A pathophysiologic and therapeutic makeover
Unger, R. H., & Cherrington, A. D. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60016 · Cited by 670 · cited 1×
“A new interest in glucagon has arisen when it was rediscovered that the metabolic disorders observed in diabetes mellitus (DM) are not, or not only due to the lack of insulin or to insulin resistance of the target tissues, but to elevated glucagon levels (6, 66, 103, 106, 107, 164, 194).”
BackgroundBonner, C., Kerr-Conte, J., Gmyr, V., Queniat, G., Moerman, E., Thévenet, J., Beaucamps, C., Delalleau, N., Popescu, I., Malaisse, W. J., et al. (2015) · Nature Medicine · doi:10.1038/nm.3828 · Cited by 670 · cited 1×
“It has recently been shown that inhibition of the glucose transporter SGLT2 triggers glucagon secretion by -cells in patients with type 2 DM and in diabetic mice (23).”
BackgroundPhysiology of Proglucagon Peptides: Role of Glucagon and GLP-1 in Health and Disease
Sandoval, D. A., & D'Alessio, D. A. (2015) · Physiological Reviews · doi:10.1152/physrev.00013.2014 · Cited by 498 · cited 1×
“The two molecules originate from the same precursor (114), but are secreted by different organs, possess different receptors, and exert different actions on peripheral organs including the kidney (166, 171).”
BackgroundGlucagon receptor knockout prevents insulin-deficient type 1 diabetes in mice
Lee, Y., Wang, M.-Y., Du, X. Q., Charron, M. J., & Unger, R. H. (2011) · Diabetes · doi:10.2337/db10-0426 · Cited by 327 · cited 1×
“These mice exhibit a reduced blood glucose concentration (74, 173) and fail to become hyperglycemic after streptozotocin administration (61, 100, 134, 198).”
BackgroundBankir, L. (2001) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00328-5 · Cited by 300 · cited 1×
“require relatively high levels of vasopressin (16, 46, 91).”
BackgroundKelly, R. P., Garhyan, P., Raddad, E., Fu, H., Lim, C. N., Prince, M. J., Pinaire, J. A., Loh, M. T., & Deeg, M. A. (2015) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12446 · Cited by 110 · cited 1×
“New non-peptide glucagon receptor antagonists (56, 77, 108, 156, 170, 196, 205) brought significant improvement in animal models of diabetes or obesity (36, 85, 122, 123, 128, 202), and induced significant reduction of glycemia, HbA1c, or glucose production in healthy subjects or diabetic patients (88, 89, 143).”
BackgroundNarrative Review: Evolving Concepts in Potassium Homeostasis and Hypokalemia
Greenlee, M., Wingo, C. S., McDonough, A. A., Youn, J.-H., & Kone, B. C. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00008 · Cited by 104
Concentrations of Glucagon and the Insulin: Glucagon Ratio in the Portal and Peripheral Circulation
Felig, P., Gusberg, R., Hendler, R., Gump, F. E., & Kinney, J. M. (1974) · Experimental Biology and Medicine · doi:10.3181/00379727-147-38286 · Cited by 91
Influence of glucagon on GFR and on urea and electrolyte excretion: direct and indirect effects
Ahloulay, M., Dechaux, M., Laborde, K., & Bankir, L. (1995) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1995.269.2.f225 · Cited by 59
Self-citationGut sensing of dietary K+ intake increases renal K+ excretion
Oh, K.-S., Oh, Y. T., Kim, S.-W., Kita, T., Kang, I., & Youn, J. H. (2011) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00095.2011 · Cited by 55
Cited by
100 years of glucagon and 100 more
Wewer Albrechtsen, N. J., Holst, J. J., Cherrington, A. D., Finan, B., Gluud, L. L., Dean, E. D., Campbell, J. E., Bloom, S. R., Tan, T. M.-M., Knop, F. K., et al. (2023) · Diabetologia · doi:10.1007/s00125-023-05947-y · Cited by 117
“Glucagon may directly or indirectly increase heart rate [123], renal excretion of electrolytes [124] and gastric emptying [125]/peristalsis [126].”
BackgroundParker, V. E. R., Hoang, T., Schlichthaar, H., Gibb, F. W., Wenzel, B., Posch, M. G., Rose, L., Chang, Y., Petrone, M., Hansen, L., et al. (2022) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14712 · Cited by 80
Tonneijck, L., Muskiet, M. H. A., Blijdorp, C. J., Smits, M. M., Twisk, J. W., Kramer, M. H. H., Danser, A. H. J., Diamant, M., Joles, J. A., Hoorn, E. J., et al. (2019) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00432.2018 · Cited by 57
Wang, M.-Y., Zhang, Z., Zhao, S., Onodera, T., Sun, X.-N., Zhu, Q., Li, C., Li, N., Chen, S., Paredes, M., et al. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2023.12.024 · Cited by 52
Selvarajah, V., Robertson, D., Hansen, L., Jermutus, L., Smith, K., Coggi, A., Sánchez, J., Chang, Y.-T., Yu, H., Parkinson, J., et al. (2024) · Kidney International · doi:10.1016/j.kint.2024.08.023 · Cited by 49
Metadata
- Authors
- Bankir, L., Bouby, N., Blondeau, B., & Crambert, G.
- Venue
- American Journal of Physiology-Renal Physiology
- Publisher
- American Physiological Society
- Published
- 2016-08-01
- Volume
- 311
- Issue
- 2
- Pages
- F469-F486
- ISSN
- 1522-1466 (ISSN-L)
- 1931-857X
- OpenAlex
- W2399642693
- Cited by
- 61
- References
- 11
- FWCI
- 1.81
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Glucagon actions on the kidney revisited: possible role in potassium homeostasis. https://app.cochat.ai/papers/10.1152/ajprenal.00560.2015
- The paper
- Bankir, L., Bouby, N., Blondeau, B., & Crambert, G. (2016). Glucagon actions on the kidney revisited: possible role in potassium homeostasis. American Journal of Physiology-Renal Physiology. https://doi.org/10.1152/ajprenal.00560.2015
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.